curadev.in
Get leads like Curadev — and thousands more
Build targeted lists by tech stack, traffic, and more
Curadev: The Stealth Biotech Building a Cancer Arsenal
A 66-person, $10M revenue clinical-stage biotech taking on intractable diseases with small molecules
In a world where biotech giants chase the same targets, Curadev.in is quietly building a portfolio of next-generation therapeutics from a modest office in India. With 66 employees and a $10.2M revenue stream, they're not a unicorn—they're something rarer: a profitable, clinical-stage biotech proving that you can build world-class drug discovery without Silicon Valley hype.
"They're not chasing the herd—they're engineering precision weapons for diseases that have defied conventional therapy."
The STING Agonist Play
Curadev's lead asset, CRD3874-SI, is a first-in-class allosteric STING agonist currently in Phase 1 trials at Memorial Sloan Kettering Cancer Center. This isn't just another immunotherapy—it's an allosteric modulator, meaning it activates the STING pathway through a novel binding mechanism. Their collaboration with MSK's Therapeutics Accelerator signals serious scientific validation, expanding trials to multiple cancer types.
The Revenue Reality
Here's what's fascinating: Curadev generates $10.2M in revenue with just 66 employees. That's approximately $155K per employee—a remarkable efficiency ratio for a biotech. While they're not publicly traded and funding details are undisclosed, this revenue suggests they've moved beyond pure R&D burn into a sustainable model. They're likely generating income through partnerships, licensing, or contract research while building their own pipeline.
The website traffic story reveals their true audience: only 45 monthly visits with 100% from undefined countries (likely India). This isn't a consumer-facing biotech—it's a B2B scientific operation. Their top keywords ('cura pharma consultancy', 'dev pharmacy private limited') suggest they're either confused with other entities or they're quietly building a consulting arm alongside their drug discovery. The real signal? 'Immuneoncology' appears as a top keyword—exactly where their STING agonist plays.
- First-in-class allosteric STING agonist in Phase 1 trials at MSK Cancer Center
- Target-centric approach combining innovative screening with traditional wet-lab chemistry
- Profitable model with $10.2M revenue from 66 employees ($155K/employee)
- Strategic collaboration with MSK Therapeutics Accelerator for trial expansion
- Built portfolio of patent-protected drug candidates targeting next-generation pathways
The Quiet Giant of Indian Biotech
While others chase headlines, Curadev is building a war chest of next-generation cancer therapeutics with the discipline of a veteran operator.
What tech stack does Curadev use?
How much traffic does Curadev get?
Traffic & Engagement
Traffic Sources
Where is Curadev's audience located?
What keywords does Curadev rank for?
3 keywordsHow is Curadev's SEO?
Meta Tags
HOME | Curadev Pharma
H1 Tags
Schema Types
What is Curadev's revenue?
Who works at Curadev?
Loading leads...
What do customers think of Curadev?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Curadev
What is Curadev's Revenue?
How fast is Curadev growing?
What technologies does Curadev use?
Who are Curadev's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Curadev?
Export curadev.in Data
Download the complete tech stack, analytics, leads, and company data for curadev.in in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About curadev.in
Company Overview
curadev.in Social Media
Contact curadev.in
Email Addresses
Phone Numbers
Technology Stack
curadev.in uses 13 technologies across their website including Font Awesome, HSTS, Sentry, and more.
Fonts
Font Awesome
Security
HSTS
Error Tracking
Sentry
CMS
Wix
Customer Support
Zendesk
Performance
Lazy Loading, Priority Hints
Traffic & Audience
curadev.in receives approximately 45 monthly visitors and ranks #8,510,792 globally. The website has a bounce rate of 36% with visitors viewing an average of 1.0 pages per visit. Users spend an average of 0:00 on the site.
The majority of curadev.in's traffic comes from .
Frequently Asked Questions
What is curadev.in?
What technologies does curadev.in use?
How do I contact curadev.in?
What are curadev.in's social media accounts?
Is curadev.in hiring?
How popular is curadev.in?
Related Searches
This page provides publicly available information about curadev.in. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit curadev.in directly at https://curadev.in.